Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics Gets CE-IVD Mark for Genetic Tests

NEW YORK (GenomeWeb) – Sophia Genetics today said that it has received the CE-IVD mark for genetic testing of familial Mediterranean fever and hypercholesterolemia, enabling the tests to be offered in the European Union and other nations that accept the CE mark for marketing.

The tests are based on next-generation sequencing data and employ the Lausanne, Switzerland-based firm's NGS bioinformatics pipeline.

Sophia's pipelines, which are fully automated and execute DNA sequence assembly, alignment to a reference genome, variant calling, and variant annotation, obtained the CE-IVD mark for routine genetic testing earlier this month.

Familial Mediterranean fever is an inherited inflammatory disorder that causes recurrent fevers and inflammation of the abdomen, lungs, and joints. It usually affects people of Mediterranean origin.

Hypercholesterolemia is characterized by very high levels of cholesterol in the blood and can be inherited. Mutations in several genes, including APOB, LDLR, LDLRAP1, and PCSK9, cause the disease.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.